Plain-English translation of NCT05028140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This clinical trial is testing a medication called to see if it helps people with type 2 diabetes control their blood sugar levels better. Researchers will compare the medication to two other existing diabetes treatments to understand which approach works best and is safest for patients.
Many people with type 2 diabetes struggle to reach their target blood sugar levels even with diet, exercise, and current medications. This study aims to find out whether this medication could be a more effective treatment option for those who haven't reached their goals with standard care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take one pill by mouth once daily — though you'll actually receive three tablets to make sure neither you nor the researchers know which treatment you're getting, which helps keep the results fair and unbiased. You'll be randomly assigned to receive either the new medication or one of the two comparison drugs, and you'll need to follow up with the research team regularly so they can monitor your blood sugar levels and check for any side effects.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Brazil
Phase
Large-scale testing
Sponsor
EMS
Enrollment target
~480 participants
Started
October 2024
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Arthur M Kummer, MD, PhD
EMS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.